All Immuno Content

Bringing you the latest research in immuno-oncology, autoimmunity, therapeutic modalities and more, through a range of Speaker Interviews, Industry Insights, and Expert Opinions.

Video Content
Video Q&A
In this interview, Eran Ophir discusses Compugen's exciting approach to immune checkpoint inhibitors for the treatment of cancer and what makes them stand out from the crowd.
21 July 2022
Therapeutic Modalities
Commentary
Microbiotica’s live bacterial therapeutic is currently manufacturing for phase Ib trials in 2023.
19 July 2022
Therapeutic Modalities
Insight Article
Investigating the role of the microbiota in checkpoint inhibitor response.
Edited by Tom Cohen |
14 July 2022
Therapeutic Modalities
Video Content
Video Q&A
Video Interview | Namir Hassan, CEO at Zelluna Immunotherapy
05 May 2022
Therapeutic Modalities
Insight Article
The power of the genome has enormous implications for immunotherapy
Edited by Tom Cohen |
22 February 2022
Therapeutic Modalities
Video Content
Webinar
Presented by Barbara Cipriani, Head of Biology, Pathios Therapeutics
13 October 2021
Therapeutic Modalities
Video Content
Video Q&A
Video Interview | Phil Bland-Ward, CDO, Crescendo Biologics
01 June 2021
Therapeutic Modalities
Video Content
Webinar
Speakers included: Jukka Rissanen, PhD, CEO, Pharmatest Services | Sanna Käkönen, PhD, Founder, CEO, Aurexel Life Sciences Ltd, Adjunct Professor, University of Turku | Joy Wolfram, PhD, Assistant Professor, Mayo Clinic
25 May 2021
Therapeutic Modalities
Video Content
Video Q&A
Video Interview | Christopher Helsen, Director of Research & Development, Head of Platform Development, Triumvira
25 May 2021
Therapeutic Modalities
Video Content
Video Q&A
Video Interview | Victor Cervera, Head of Immunology, Tilt Biotherapeutics
14 May 2021
Therapeutic Modalities

Search by Keyword

Filter by Subject Area

Filter by Content Type

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login